Clinical Trial Showdown: Head-to-Head Data When measuring efficacy, clinical trial percentages tell a definitive story
Post hoc analysis by CV risk Pooled key baseline characteristics, CV risk factors, and manifestation of CVD at baseline for the two CV subgroups [subjects with prior MI or stroke vs no prior MI or stroke and subjects with established CVD vs risk factors only (including CKD)] are shown in Table 1C
The timing of symptom onset in relation to medication initiation should be carefully considered, but other causes must be systematically excluded
These include: Nausea (very common, affecting up to 20% of patients) Diarrhoea (very common) Vomiting (common) Abdominal pain (common) Constipation (common) Dyspepsia (common) These gastrointestinal effects typically emerge during treatment initiation or dose escalation and often diminish over time as the body adapts to the medication
No other current oral GLP-1 treatment can match the weight loss delivered by the Wegovy pill, and we are very excited for what this will mean for patients in the US
Its crucial to store semaglutide within the recommended temperature range, usually between 36F to 46F (2C to 8C), to maintain its efficacy